Results 241 to 250 of about 9,860,660 (392)

A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis

open access: yesArthritis &Rheumatology, Accepted Article.
Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane   +33 more
wiley   +1 more source

AI-Assisted Optical Coherence Tomography Segmentation for Enhanced Diagnosis of Inherited Retinal Diseases. [PDF]

open access: yesTransl Vis Sci Technol
Peter VG   +5 more
europepmc   +1 more source

Retinal small vessel pathology is associated with disease burden in multiple sclerosis [PDF]

open access: hybrid
Rebecca Wicklein   +8 more
openalex   +1 more source

Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step toward Precision Drug Monitoring

open access: yesArthritis &Rheumatology, Accepted Article.
Background Using hydroxychloroquine (HCQ) dose of 5 mg/kg/day in systemic lupus erythematosus (SLE) is associated with a higher risk of flares; HCQ blood level monitoring could be a better way to adjust HCQ dose. We studied the upper threshold for a reference range of HCQ levels to inform routine monitoring.
Shivani Garg   +42 more
wiley   +1 more source

Cell-based regenerative therapy for retinal diseases: challenges and emerging bioengineering strategies. [PDF]

open access: yesRegen Ther
Iwama Y   +6 more
europepmc   +1 more source

Screening for diabetic retinopathy and other retinal diseases: a telemedicine project in Mexico

open access: green, 2019
Dalia Méndez Marín   +10 more
openalex   +1 more source

A New Era for Using Natural Pigments: The Case of the C50 Carotenoid Called Bacterioruberin

open access: yesBiotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Haloarchaea are extremophilic microorganisms belonging to the Archaea domain that require high salt concentrations to live, thus inhabiting ecosystems like salty ponds, salty marshes, or extremely salty lagoons. They are more abundant and widely distributed worldwide than initially expected.
Micaela Giani   +5 more
wiley   +1 more source

Therapeutic potential of P2X7 receptor in retinal diseases. [PDF]

open access: yesPurinergic Signal
Wen M   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy